iShares Genomics Immunology and Healthcare ETF
Limited financial coverage for IDNA.
Not enough data to compute a meaningful composite — typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available stats still render below.
About the company
The iShares Genomics Immunology and Healthcare ETF (IDNA) is designed to mirror the investment performance of a specific index. This index comprises companies operating in both mature and emerging global markets. These businesses are strategically chosen for their potential to capitalize on sustained innovation and expansion within the crucial fields of genomics, immunology, and bioengineering.
- IPO
- 2019
- HQ
- New York, NY, US
Price Chart
- Market Cap
- $163.69M
- Div Yield
- 0.80%
- 52W High
- $34.92
- 52W Low
- $20.56
- 50D MA
- $30.14
- 200D MA
- $27.99
- Beta
- 1.11
- Avg Volume
- 48.51K
Get TickerSpark's AI analysis on IDNA
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our IDNA coverage
Recent articles, reports, and earnings notes.
No research on IDNA yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate IDNA report →Similar companies
Peers in the same neighborhood.